We have improved our capital plan. We have improved our capital efficiency. We have improved and have a clear path to ...

If you are wondering whether Advantest's recent share price puts it at a premium or leaves some value on the table, this article will walk through what the numbers actually say about the stock.

Solventum (NYSE: SOLV) today reported financial results for the fourth quarter and year ended December 31, 2025.

The Tribunal held that Customs cannot reject a higher transaction value to redetermine a lower value for imposing anti-dumping duty. Rule 12 does not authorize downward revision merely to levy ...